Meet our esteemed speakers and faculty

Dr. Ilham OULHOUS

Dermatologist, Morocco

“I always start with temple restoration because it ensures a natural result. This area is anatomically complex and requires high precision. I’m excited to share my passion for temple restoration with you. Join me at IMCAS Paris! See you soon.”

Iman MIR

Industry representative, Iran

“Join Me at IMCAS World Congress 2025! Excited to present "Medical Tourism: A Comprehensive Guide to Becoming a Global Leader" at IMCAS 2025! I'll be sharing insights on industry trends, key strategies, and innovations shaping global healthcare travel. 📅 Date: Saturday, 1 February 2025 📍 Room: 342 - Level 3 🕘 Time: 09:33 Don't miss this opportunity to network, learn, and explore the future of medical tourism! See you in Paris! 🌍✈️ #IMCAS2025 #MedicalTourism #GlobalHealthcare”

Dr. Gustavo H LEIBASCHOFF

Gynecologist, United States

“Not only do the years make us more adult, but they give us the maturity to be able to discern between what works or not, IMCAS is the place where the doctor finds the information and training that will help him provide better care to her/his patients. And I say this with the authority that 50 years as a doctor and 40 in the world of aesthetic medicine give me (which is a very broad term that includes clinic, surgery, gynecology among other branches of medicine)”

Dr. Alessandro ALARCAO

Dermatologist, Brazil

“ I’m honored to be part of IMCAS 2025, one of the world’s leading aesthetic congresses. I’ll be sharing insights on gluteal enhancement techniques. I warmly invite colleagues and patients worldwide to join me on this journey. Let’s grow and learn together! ”

Dr. Konstantinos GKRITZALAS

Cosmetic Surgeon, Greece

“ Welcome Letter Dear Colleagues, It is with great enthusiasm and honor that I welcome you to the [ IMCAS 2025 This remarkable gathering of experts, innovators, and pioneers in the field of aesthetic medicine serves as a platform for the exchange of ideas, breakthroughs, and collaborations that will shape the future of our practice. dr Konstantinos Gkritzalas Dermatologist Master Aesthetic medicine ”

Prof Jean Paul MENINGAUD

Plastic Surgeon, France

“Dear Colleagues, I am excited to announce that I will be presenting at the upcoming International Master Course on Aging Science (IMCAS) in Paris. My presentation, titled "Are Platysmal Transection and Salivary Gland Removal Necessary in Neck Lifting?", will explore the intricacies and efficacy of these surgical techniques within the context of facial rejuvenation. This session will delve into the latest advancements in lifting procedures, focusing on whether traditional approaches are still n”

Dr. Cosimo OLIVA

Gynecologist, Italy

“"AIGEF (Italian Association of Aesthetic and Functional Gynecology), proud Scientific Partner of the IMCAS World Congress, warmly invites you to join this global event, where excellence meets innovation. Represented by Dr. Elena Fasola and Dr. Cosimo Oliva, we look forward to sharing groundbreaking advancements and fostering inspiring discussions. Don’t miss this exceptional opportunity to shape the future of our field, aesthetic gynecology!" ”

Dr. Hebert LAMBLET

Plastic Surgeon, Brazil

“Join me at IMCAS World Congress 2025 in Paris, where I’ll present “Clinical Outcomes of Fat Grafting for Eyebrow Enhancement: Lessons from Retrospective Case Analyses.” Discover innovative techniques, best practices, and insights into achieving optimal results with fat grafting for facial rejuvenation. IMCAS is where the world’s leading experts meet to share cutting-edge advancements, foster collaboration, and set new standards in aesthetic medicine. I’m excited to connect, learn, and inspire t”

Dr. Rachita DHURAT

Dermatologist, India

“Cetirizine has demonstrated inhibitory effects on prostaglandin D2 synthesis, a molecule implicated in the pathogenesis of hair follicle miniaturization in AGA. In our case series there was an increase in the hair count as compared to the baseline in 9/9 subjects post 16 weeks of therapy. The mean hair count at week 0 was 139.56 (SE of mean of 13.92) and at 16 weeks was 163.44 (SE of mean of 15.52). Cetirizine presents a potential addition to the therapeutic armamentarium for AGA.”